Show simple item record

dc.contributor.authorJames, N
dc.contributor.authorSydes, M
dc.contributor.authorClarke, Noel W
dc.contributor.authorMason, M
dc.contributor.authorDearnaley, D
dc.contributor.authorSpears, M
dc.contributor.authorRitchie, A
dc.contributor.authorRussell, J
dc.contributor.authorParker, C
dc.contributor.authorRentsch, C
dc.contributor.authorWallace, J
dc.contributor.authorBarber, J
dc.contributor.authorLydon, A
dc.contributor.authorParmer, M
dc.date.accessioned2016-08-10T11:17:55Z
dc.date.available2016-08-10T11:17:55Z
dc.date.issued2016
dc.identifier.citationCelecoxib with or without zoledronic acid for hormone-naive prostate cancer: Survival results from STAMPEDE (NCT00268476). 2016, 34(2):162-2 J Clin Oncolen
dc.identifier.urihttp://hdl.handle.net/10541/618189
dc.language.isoenen
dc.titleCelecoxib with or without zoledronic acid for hormone-naive prostate cancer: Survival results from STAMPEDE (NCT00268476).en
dc.typeMeetings and Proceedingsen
dc.contributor.departmentUniversity of Warwick, Coventryen
dc.identifier.journalJournal of Clinical Oncologyen


This item appears in the following Collection(s)

Show simple item record